Coverage by the News Media of the Benefits and Risks of Medications
Dennis Ross-Degnan
New England Journal of Medicine, 2000
View PDFchevron_right
News Media Coverage of Medication Research
Danny McCormick
JAMA, 2008
View PDFchevron_right
Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs
Alan Cassels
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2003
View PDFchevron_right
Drugs in the News How well do Canadian newspapers report the good, the bad and the ugly of new prescription drugs?
James McCormack
View PDFchevron_right
Drug advertising in medical journals
Julian Librero
Lancet, 2003
View PDFchevron_right
Making decisions about benefits and harms of medicines
Trisha Greenhalgh
BMJ, 2004
View PDFchevron_right
Medicines and the media: news reports of medicines recommended for government reimbursement in Australia
David A Newby
BMC Public Health, 2013
View PDFchevron_right
Benefits, risks, and costs of prescription drugs: a scientific basis for evaluating policy options
Ulf Bergman
Clinical pharmacology …, 1990
View PDFchevron_right
The true cost of pharmacological disease prevention
Teppo Järvinen
BMJ, 2011
View PDFchevron_right
The potential for bias in reporting of industry-sponsored clinical trials
James Matcham
Pharmaceutical Statistics, 2011
View PDFchevron_right
Does pharmaceutical advertising affect journal publication about dietary supplements?
Kathi Kemper
BMC Complementary and Alternative Medicine, 2008
View PDFchevron_right
Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies
Su Golder
British Journal of Clinical Pharmacology, 2008
View PDFchevron_right
The impact of scientific evidence and price level of hypertension drug therapies on their market performance – A Europe based analysis
Bence Kovács
Vezetéstudomány / Budapest Management Review, 2017
View PDFchevron_right
The association between a journal's source of revenue and the drug recommendations made in the articles it publishes
Erika Baum
Canadian Medical Association Journal, 2011
View PDFchevron_right
The commercial contribution of clinical studies for pharmaceutical drugs
Stefan Stremersch, Ashish Sood
International Journal of Research in Marketing, 2014
View PDFchevron_right
Correspondenceof claims, references and the presentation of risk results in medical journal advertising: a comparative study in Australia, Malaysia and the United States
noordin othman
Bmc Public Health, 2010
View PDFchevron_right
Trends in Antihypertensive Drug Advertising, 1985-1996
John Ccb
2010
View PDFchevron_right
News coverage about aspirin as a countervailing force against low-dose aspirin campaign promotion
Milton Eder
Translational Behavioral Medicine, 2021
View PDFchevron_right
E Selling Drugs: Marketing Strategies in the Pharmaceutical Industry and their Effect on Healthcare and Research
Mustafa Alattab
View PDFchevron_right
EVALUATION OF DRUG ADVERTISEMENTS IN A MEDICAL JOURNALThough ideally the scientific information provided by pharmaceutical companies in drug advertisements should be for promotion of rational use of drugs, this objective is rarely achieved, as often the d
Aersh Danish
Journal of Nepal Medical Association, 2003
View PDFchevron_right
Benefits and risks of medications: challenges for the 21st century
Harold Slavkin
Journal of the American Dental Association, 1997
View PDFchevron_right
Pharmaceuticals: natures of research and distributions of knowledge
Sergio Sismondo
View PDFchevron_right
Adherence of Pharmaceutical Advertisements in Medical Journals to FDA Guidelines and Content for Safe Prescribing
Salomeh Keyhani
PLoS ONE, 2011
View PDFchevron_right
The Inverse Benefit Law: How Drug Marketing Undermines Patient Safety and Public Health
Donald Light
American Journal of Public Health, 2011
View PDFchevron_right
Reinvigorating the concept of benefit: the failure of drug company-sponsored research on human subjects
Jacqueline Fox
Seton Hall law review, 2008
View PDFchevron_right